Drug firm Ipca Laboratories Ltd today reported a net profit of Rs 76.61 crore for the fourth quarter ended March 31, 2012.
The company had posted a net profit of Rs 58.57 crore for the fourth quarter ended March 31, 2012, Ipca Laboratories said in a filing to the BSE.
The net sales of the company stood at Rs 553.11 crore in the quarter under review. It stood at Rs 473.78 crore in the same period of previous fiscal.
The financial figures of the current quarter and fiscal are not comparable with those of the previous financial year due to amalgamation of Tonira Pharma with the company with effect from April 1, 2011, it said.
For the year ended Mach 31, 2012, the company reported a net profit of Rs 280.17 crore. The profit stood at Rs 255.37 crore during 2010-11.
The company's board, which met today, recommended a final dividend of Rs 1.20 per share of Rs 2 each (60 per cent) for the financial year 2011-12.
Shares of Ipca Laboratories were trading at Rs 325.70 on the BSE in late afternoon trade, down 2.76 per cent from its previous close.